Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Rationale and Design for the Remote Ischemic Preconditioning for Carotid Endarterectomy Trial.

Sridharan ND, Robinson D, Thirumala P, Arak A, Olafiranye O, Tzeng E, Avgerinos E.

Ann Vasc Surg. 2019 Jun 12. pii: S0890-5096(19)30368-1. doi: 10.1016/j.avsg.2019.03.014. [Epub ahead of print]

PMID:
31200043
2.

Design of The PReferences for Open Versus Endovascular Repair of Abdominal Aortic Aneurysm (PROVE-AAA) Trial.

Columbo JA, Kang R, Spangler EL, Newhall K, Brooke BS, Dosluoglu H, Lee ES, Raffetto JD, Henke PK, Tang GS, Mureebe L, Kougias P, Johanning J, Arya S, Scali ST, Stone DH, Suckow BD, Orion K, Halpern V, O'Connell J, Inhat D, Nelson P, Tzeng E, Zhou W, Barry M, Sirovich B, Goodney PP; PROVE-AAA Study Team.

Ann Vasc Surg. 2019 May 7. pii: S0890-5096(19)30289-4. doi: 10.1016/j.avsg.2019.02.034. [Epub ahead of print] Review.

PMID:
31075459
3.

Active wrinkles to drive self-cleaning: A strategy for anti-thrombotic surfaces for vascular grafts.

Pocivavsek L, Ye SH, Pugar J, Tzeng E, Cerda E, Velankar S, Wagner WR.

Biomaterials. 2019 Feb;192:226-234. doi: 10.1016/j.biomaterials.2018.11.005. Epub 2018 Nov 5.

PMID:
30458358
4.

Persistently low inferior vena cava filter retrieval rates in a population-based cohort.

Mohapatra A, Liang NL, Chaer RA, Tzeng E.

J Vasc Surg Venous Lymphat Disord. 2019 Jan;7(1):38-44. doi: 10.1016/j.jvsv.2018.08.006. Epub 2018 Nov 12.

PMID:
30442582
5.

Implementation of drug-eluting stents for the treatment of femoropopliteal disease provides significant cost-to-system savings in a single-state outpatient simulation.

Sridharan ND, Liang N, Robinson D, Avgerinos E, Tzeng E, Makaroun MS, Chaer RA, Eslami MH.

J Vasc Surg. 2018 Nov;68(5):1465-1472. doi: 10.1016/j.jvs.2018.02.040. Epub 2018 May 18.

6.

Comparable perioperative mortality outcomes in younger patients undergoing elective open and endovascular abdominal aortic aneurysm repair.

Liang NL, Reitz KM, Makaroun MS, Malas MB, Tzeng E.

J Vasc Surg. 2018 May;67(5):1404-1409.e2. doi: 10.1016/j.jvs.2017.08.057. Epub 2017 Oct 31.

7.

Chloroquine improves the response to ischemic muscle injury and increases HMGB1 after arterial ligation.

Xu J, Cui X, Li J, Koutakis P, Pipinos I, Tzeng E, Chen A, Sachdev U.

J Vasc Surg. 2018 Mar;67(3):910-921. doi: 10.1016/j.jvs.2017.01.021. Epub 2017 Mar 1.

8.

My Continuing Evolution as a Surgeon-Scientist: A Decade after the Jacobson Promising Investigator Award.

Tzeng E.

J Am Coll Surg. 2017 Jan;224(1):75-78. doi: 10.1016/j.jamcollsurg.2016.09.012. Epub 2016 Oct 8.

9.

A depleting antibody toward sca-1 mitigates a surge of CD34(+)/c-kit(+) progenitors and reduces vascular restenosis in a murine vascular injury model.

Tillman BW, Kelly J, Richards TD, Chen AF, Donnenberg AD, Donnenberg VS, Tzeng E.

J Vasc Surg. 2016 Oct;64(4):1084-92. doi: 10.1016/j.jvs.2015.05.002.

10.

Somatosensory Evoked Potentials and Electroencephalography during Carotid Endarterectomy Predict Late Stroke but not Death.

Domenick Sridharan N, Chaer RA, Thirumala PD, Balzer J, Long B, Tzeng E, Makaroun MS, Avgerinos ED.

Ann Vasc Surg. 2017 Jan;38:105-112. doi: 10.1016/j.avsg.2016.07.064. Epub 2016 Aug 10.

11.

TLR4 Deters Perfusion Recovery and Upregulates Toll-like Receptor 2 (TLR2) in Ischemic Skeletal Muscle and Endothelial Cells.

Xu J, Benabou K, Cui X, Madia M, Tzeng E, Billiar T, Watkins S, Sachdev U.

Mol Med. 2015 Jul 14;21:605-15. doi: 10.2119/molmed.2014.00260.

12.

Xanthine Oxidoreductase Function Contributes to Normal Wound Healing.

Madigan MC, McEnaney RM, Shukla AJ, Hong G, Kelley EE, Tarpey MM, Gladwin M, Zuckerbraun BS, Tzeng E.

Mol Med. 2015 Apr 14;21:313-22. doi: 10.2119/molmed.2014.00191.

13.

P2Y2 nucleotide receptor mediates arteriogenesis in a murine model of hind limb ischemia.

McEnaney RM, Shukla A, Madigan MC, Sachdev U, Tzeng E.

J Vasc Surg. 2016 Jan;63(1):216-25. doi: 10.1016/j.jvs.2014.06.112. Epub 2014 Jul 31.

14.

MyD88 and TRIF mediate divergent inflammatory and regenerative responses to skeletal muscle ischemia.

Sachdev U, Cui X, Xu J, Xu J, Tzeng E.

Physiol Rep. 2014 May 20;2(5). pii: e12006. doi: 10.14814/phy2.12006. Print 2014 May 1.

15.

Distinct phenotype of a Wilson disease mutation reveals a novel trafficking determinant in the copper transporter ATP7B.

Braiterman LT, Murthy A, Jayakanthan S, Nyasae L, Tzeng E, Gromadzka G, Woolf TB, Lutsenko S, Hubbard AL.

Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):E1364-73. doi: 10.1073/pnas.1314161111. Epub 2014 Mar 24.

16.

Delayed inhaled carbon monoxide mediates the regression of established neointimal lesions.

Madigan M, Entabi F, Zuckerbraun B, Loughran P, Tzeng E.

J Vasc Surg. 2015 Apr;61(4):1026-33. doi: 10.1016/j.jvs.2013.11.072. Epub 2014 Jan 11.

17.

Nitric oxide, a protective molecule in the cardiovascular system.

Lei J, Vodovotz Y, Tzeng E, Billiar TR.

Nitric Oxide. 2013 Nov 30;35:175-85. doi: 10.1016/j.niox.2013.09.004. Epub 2013 Oct 1. Review.

PMID:
24095696
18.

HMGB1 and TLR4 mediate skeletal muscle recovery in a murine model of hindlimb ischemia.

Sachdev U, Cui X, Tzeng E.

J Vasc Surg. 2013 Aug;58(2):460-9. doi: 10.1016/j.jvs.2012.11.071. Epub 2013 Feb 12.

19.

TLR2 and TLR4 mediate differential responses to limb ischemia through MyD88-dependent and independent pathways.

Sachdev U, Cui X, McEnaney R, Wang T, Benabou K, Tzeng E.

PLoS One. 2012;7(11):e50654. doi: 10.1371/journal.pone.0050654. Epub 2012 Nov 29.

20.

Nitrite-generated nitric oxide to protect against intimal hyperplasia formation.

Ataya B, Tzeng E, Zuckerbraun BS.

Trends Cardiovasc Med. 2011 Aug;21(6):157-62. doi: 10.1016/j.tcm.2012.05.002. Review.

PMID:
22814422
21.

Nitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia.

Alef MJ, Tzeng E, Zuckerbraun BS.

Nitric Oxide. 2012 May 15;26(4):285-94. doi: 10.1016/j.niox.2012.03.014. Epub 2012 Apr 5. Review.

PMID:
22504069
22.

Delayed open conversions after endovascular abdominal aortic aneurysm repair.

Chaar CI, Eid R, Park T, Rhee RY, Abu-Hamad G, Tzeng E, Makaroun MS, Cho JS.

J Vasc Surg. 2012 Jun;55(6):1562-9.e1. doi: 10.1016/j.jvs.2011.12.007. Epub 2012 Apr 11.

23.

High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury.

Sachdev U, Cui X, Hong G, Namkoong S, Karlsson JM, Baty CJ, Tzeng E.

J Vasc Surg. 2012 Jan;55(1):180-91. doi: 10.1016/j.jvs.2011.07.072. Epub 2011 Sep 23.

24.

Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.

Powell RJ, Comerota AJ, Berceli SA, Guzman R, Henry TD, Tzeng E, Velazquez O, Marston WA, Bartel RL, Longcore A, Stern T, Watling S.

J Vasc Surg. 2011 Oct;54(4):1032-41. doi: 10.1016/j.jvs.2011.04.006. Epub 2011 Jul 31.

25.

Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats.

Alef MJ, Vallabhaneni R, Carchman E, Morris SM Jr, Shiva S, Wang Y, Kelley EE, Tarpey MM, Gladwin MT, Tzeng E, Zuckerbraun BS.

J Clin Invest. 2011 Apr;121(4):1646-56. doi: 10.1172/JCI44079. Epub 2011 Mar 23.

26.

Early hypercholesterolemia contributes to vasomotor dysfunction and injury associated atherogenesis that can be inhibited by nitric oxide.

Raman KG, Gandley RE, Rohland J, Zenati MS, Tzeng E.

J Vasc Surg. 2011 Mar;53(3):754-63. doi: 10.1016/j.jvs.2010.09.038. Epub 2010 Dec 15.

27.

Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts.

Nakao A, Huang CS, Stolz DB, Wang Y, Franks JM, Tochigi N, Billiar TR, Toyoda Y, Tzeng E, McCurry KR.

Cardiovasc Res. 2011 Feb 1;89(2):457-63. doi: 10.1093/cvr/cvq298. Epub 2010 Sep 16.

28.

Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury.

Wegiel B, Gallo DJ, Raman KG, Karlsson JM, Ozanich B, Chin BY, Tzeng E, Ahmad S, Ahmed A, Baty CJ, Otterbein LE.

Circulation. 2010 Feb 2;121(4):537-48. doi: 10.1161/CIRCULATIONAHA.109.887695. Epub 2010 Jan 18.

29.

Carbon monoxide: vascular therapeutic for the future.

Tzeng E.

Vascular. 2009 May-Jun;17 Suppl 1:S55-62. Review.

PMID:
19426610
30.
31.

Thioredoxin catalyzes the denitrosation of low-molecular mass and protein S-nitrosothiols.

Sengupta R, Ryter SW, Zuckerbraun BS, Tzeng E, Billiar TR, Stoyanovsky DA.

Biochemistry. 2007 Jul 17;46(28):8472-83. Epub 2007 Jun 20.

PMID:
17580965
32.

Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.

Wu C, Ma MH, Brown KR, Geisler M, Li L, Tzeng E, Jia CY, Jurisica I, Li SS.

Proteomics. 2007 Jun;7(11):1775-85.

PMID:
17474147
33.

Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA.

Zuckerbraun BS, Stoyanovsky DA, Sengupta R, Shapiro RA, Ozanich BA, Rao J, Barbato JE, Tzeng E.

Am J Physiol Cell Physiol. 2007 Feb;292(2):C824-31. Epub 2006 Aug 16.

34.

Inhaled carbon monoxide inhibits intimal hyperplasia and provides added benefit with nitric oxide.

Raman KG, Barbato JE, Ifedigbo E, Ozanich BA, Zenati MS, Otterbein LE, Tzeng E.

J Vasc Surg. 2006 Jul;44(1):151-8.

35.

Can computed tomography scan findings predict "impending'' aneurysm rupture?

Boules TN, Compton CN, Stanziale SF, Sheehan MK, Dillavou ED, Gupta N, Tzeng E, Makaroun MS.

Vasc Endovascular Surg. 2006 Jan-Feb;40(1):41-7.

PMID:
16456605
36.

Inhibition of geranylgeranyltransferase I decreases generation of vascular reactive oxygen species and increases vascular nitric oxide production.

Zuckerbraun BS, Barbato JE, Hamilton A, Sebti S, Tzeng E.

J Surg Res. 2005 Apr;124(2):256-63.

PMID:
15820256
37.

Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome.

Barbato JE, Zuckerbraun BS, Overhaus M, Raman KG, Tzeng E.

Am J Physiol Heart Circ Physiol. 2005 Jul;289(1):H228-36. Epub 2005 Feb 25.

38.

iNOS gene transfer for graft disease.

Barbato JE, Tzeng E.

Trends Cardiovasc Med. 2004 Oct;14(7):267-72. Review.

PMID:
15542378
39.

Intratracheal adenoviral-mediated delivery of iNOS decreases pulmonary vasoconstrictor responses in rats.

Chicoine LG, Tzeng E, Bryan R, Saenz S, Paffett ML, Jones J, Lyons CR, Resta TC, Nelin LD, Walker BR.

J Appl Physiol (1985). 2004 Nov;97(5):1814-22. Epub 2004 Jul 16.

40.

Nitric oxide and arterial disease.

Barbato JE, Tzeng E.

J Vasc Surg. 2004 Jul;40(1):187-93. Review.

41.

Adenovirus-mediated nitric oxide synthase gene transfer.

Raman KG, Shapiro RA, Tzeng E, Kibbe MR.

Methods Mol Biol. 2004;279:225-34.

PMID:
15199249
42.

Disease progression in contralateral carotid artery is common after endarterectomy.

Raman KG, Layne S, Makaroun MS, Kelley ME, Rhee RY, Tzeng E, Muluk VS, Muluk SC.

J Vasc Surg. 2004 Jan;39(1):52-7.

PMID:
14718813
43.

The emerging role of gene therapy in the treatment of cardiovascular diseases.

Barbato JE, Kibbe MR, Tzeng E.

Crit Rev Clin Lab Sci. 2003 Oct;40(5):499-545. Review.

PMID:
14653356
44.

Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation.

Zuckerbraun BS, McCloskey CA, Mahidhara RS, Kim PK, Taylor BS, Tzeng E.

J Vasc Surg. 2003 Oct;38(4):812-9.

45.

Does hostile neck anatomy preclude successful endovascular aortic aneurysm repair?

Dillavou ED, Muluk SC, Rhee RY, Tzeng E, Woody JD, Gupta N, Makaroun MS.

J Vasc Surg. 2003 Oct;38(4):657-63.

46.

RhoA influences the nuclear localization of extracellular signal-regulated kinases to modulate p21Waf/Cip1 expression.

Zuckerbraun BS, Shapiro RA, Billiar TR, Tzeng E.

Circulation. 2003 Aug 19;108(7):876-81. Epub 2003 Jul 21.

PMID:
12874183
47.

Nitric oxide synthase gene transfer for erectile dysfunction in a rat model.

Chancellor MB, Tirney S, Mattes CE, Tzeng E, Birder LA, Kanai AJ, de Groat WC, Huard J, Yoshimura N.

BJU Int. 2003 May;91(7):691-6.

48.

Regulation of tissue factor expression in smooth muscle cells with nitric oxide.

Kibbe MR, Johnnides C, Gleixner S, Kovesdi I, Lizonova A, Zuckerbraun B, Billiar TR, Tzeng E, Muluk SC.

J Vasc Surg. 2003 Mar;37(3):650-9.

49.

Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury.

Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, Soares MP.

Nat Med. 2003 Feb;9(2):183-90. Epub 2003 Jan 21.

PMID:
12539038
50.

Maternity policy and practice during surgery residency: how we do it.

Carty SE, Colson YL, Garvey LS, Schuchert VD, Schwentker A, Tzeng E, Corcoran NA, Simmons RL, Webster MW, Billiar TR.

Surgery. 2002 Oct;132(4):682-7; discussion 687-8.

PMID:
12407353

Supplemental Content

Support Center